| 1 | presentation for more complete | | | | | | | 2 | 0.33% |
| 2 | for more complete details | | | | | | | 2 | 0.33% |
| 3 | please refer to our | | | | | | | 2 | 0.33% |
| 4 | with the query tool | | | | | | | 1 | 0.17% |
| 5 | current cohort as of | | | | | | | 1 | 0.17% |
| 6 | page current cohort as | | | | | | | 1 | 0.17% |
| 7 | samples on the requests | | | | | | | 1 | 0.17% |
| 8 | request samples on the | | | | | | | 1 | 0.17% |
| 9 | to request samples on | | | | | | | 1 | 0.17% |
| 10 | how to request samples | | | | | | | 1 | 0.17% |
| 11 | learn how to request | | | | | | | 1 | 0.17% |
| 12 | and learn how to | | | | | | | 1 | 0.17% |
| 13 | tool and learn how | | | | | | | 1 | 0.17% |
| 14 | query tool and learn | | | | | | | 1 | 0.17% |
| 15 | the query tool and | | | | | | | 1 | 0.17% |
| 16 | you can browse our | | | | | | | 1 | 0.17% |
| 17 | can browse our repositories | | | | | | | 1 | 0.17% |
| 18 | as of may 1 2024 3390 participants | | | | | | | 1 | 0.17% |
| 19 | resource you can browse | | | | | | | 1 | 0.17% |
| 20 | our resource you can | | | | | | | 1 | 0.17% |
| 21 | utilizing our resource you | | | | | | | 1 | 0.17% |
| 22 | in utilizing our resource | | | | | | | 1 | 0.17% |
| 23 | interested in utilizing our | | | | | | | 1 | 0.17% |
| 24 | you are a scientist | | | | | | | 1 | 0.17% |
| 25 | if you are a | | | | | | | 1 | 0.17% |
| 26 | investigators if you are | | | | | | | 1 | 0.17% |
| 27 | external investigators if you | | | | | | | 1 | 0.17% |
| 28 | and external investigators if | | | | | | | 1 | 0.17% |
| 29 | internal and external investigators | | | | | | | 1 | 0.17% |
| 30 | cohort as of may 1 | | | | | | | 1 | 0.17% |
| 31 | enrolled into the clinical | | | | | | | 1 | 0.17% |
| 32 | of may 1 2024 3390 participants have | | | | | | | 1 | 0.17% |
| 33 | material to the bank | | | | | | | 1 | 0.17% |
| 34 | us please refer to | | | | | | | 1 | 0.17% |
| 35 | the us please refer | | | | | | | 1 | 0.17% |
| 36 | across the us please | | | | | | | 1 | 0.17% |
| 37 | sites across the us | | | | | | | 1 | 0.17% |
| 38 | clinical sites across the | | | | | | | 1 | 0.17% |
| 39 | and 17 hiv individuals at four | | | | | | | 1 | 0.17% |
| 40 | 260 hiv individuals and 17 hiv individuals at | | | | | | | 1 | 0.17% |